These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 23911102)
1. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial. Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102 [TBL] [Abstract][Full Text] [Related]
2. Topical Tranexamic Acid Compared With Anterior Nasal Packing for Treatment of Epistaxis in Patients Taking Antiplatelet Drugs: Randomized Controlled Trial. Zahed R; Mousavi Jazayeri MH; Naderi A; Naderpour Z; Saeedi M Acad Emerg Med; 2018 Mar; 25(3):261-266. PubMed ID: 29125679 [TBL] [Abstract][Full Text] [Related]
3. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial. Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282 [TBL] [Abstract][Full Text] [Related]
4. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department. Logan JK; Pantle H Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971 [TBL] [Abstract][Full Text] [Related]
5. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial. Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025 [TBL] [Abstract][Full Text] [Related]
6. Intranasal Topical Application of Tranexamic Acid in Atraumatic Anterior Epistaxis: A Double-Blind Randomized Clinical Trial. Hosseinialhashemi M; Jahangiri R; Faramarzi A; Asmarian N; Sajedianfard S; Kherad M; Soltaniesmaeili A; Babaei A Ann Emerg Med; 2022 Sep; 80(3):182-188. PubMed ID: 35752521 [TBL] [Abstract][Full Text] [Related]
7. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study. Clinkard D; Barbic D CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087 [TBL] [Abstract][Full Text] [Related]
8. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department. Birmingham AR; Mah ND; Ran R; Hansen M Am J Emerg Med; 2018 Jul; 36(7):1242-1245. PubMed ID: 29602670 [TBL] [Abstract][Full Text] [Related]
9. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol. Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866 [TBL] [Abstract][Full Text] [Related]
10. Topical tranexamic acid for the treatment of epistaxis in patients using antiplatelet agents. Sanderson M; Powell J; Lang E CJEM; 2018 Sep; 20(5):774-776. PubMed ID: 30205859 [TBL] [Abstract][Full Text] [Related]
11. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED? Hassen GW; Clemons P; Kaplun M; Kalantari H Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis. Whitworth K; Johnson J; Wisniewski S; Schrader M J Emerg Med; 2020 Feb; 58(2):211-216. PubMed ID: 31899024 [TBL] [Abstract][Full Text] [Related]
13. Appropriate dose of tranexamic acid in the topical treatment of anterior epistaxis, 500 mg vs 1000 mg: A double-blind randomized controlled trial. Arikan C; Akyol PY Sci Prog; 2024; 107(4):368504241264993. PubMed ID: 39351623 [TBL] [Abstract][Full Text] [Related]
14. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis. Hilton L; Reuben A Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097 [TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Mathiasen RA; Cruz RM Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662 [TBL] [Abstract][Full Text] [Related]
16. Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis. Gottlieb M; DeMott JM; Peksa GD Ann Pharmacother; 2019 Jun; 53(6):652-657. PubMed ID: 30577703 [TBL] [Abstract][Full Text] [Related]
17. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
18. Is Tranexamic Acid (TXA) Effective Compared with Anterior Nasal Packing (ANP) in Achieving Cessation of Bleeding in Patients with Anterior Epistaxis? Torres E; Johnson MY; Seebald K; Kachhi P J Emerg Med; 2022 Jun; 62(6):820-825. PubMed ID: 35545485 [No Abstract] [Full Text] [Related]
19. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464 [TBL] [Abstract][Full Text] [Related]
20. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis? Bridwell RE; April MD; Long B Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746 [No Abstract] [Full Text] [Related] [Next] [New Search]